Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Maravai Lifesciences HoldingsMRVI | Open-market sale10b5-1 plan | 06/09–06/10 | 06/10 | 50,000 sh2 trades | $5.08avg. | $254,000 | −13.0% | |
Maravai Lifesciences HoldingsMRVI | Open-market buy | 25/12/05–25/12/08 | 25/12/09 | 100,000 sh2 trades | $3.69avg. | $368,544.16 | +181.4% | |
Bernd BrustCEO | Maravai Lifesciences HoldingsMRVI | Open-market buy | 25/11/13 | 25/11/17 | 216,212 sh | $3.25 | $702,689 | +86.3% |
Maravai Lifesciences HoldingsMRVI | Open-market buy | 25/11/11–25/11/12 | 25/11/13 | 250,559 sh2 trades | $3.23avg. | $809,010.42 | No record | |
Oreshack KurtGeneral Counsel | Maravai Lifesciences HoldingsMRVI | Open-market sale10b5-1 plan | 25/01/31 | 25/01/31 | 25,000 sh | $5.03 | $125,750 | −13.0% |
John A. DeFordDirector | Maravai Lifesciences HoldingsMRVI | Open-market buy | 24/11/12 | 24/11/14 | 17,500 sh | $5.75 | $100,625 | +33.3% |
Carl HullSEE REMARKS | Maravai Lifesciences HoldingsMRVI | Open-market buy | 24/11/11 | 24/11/12 | 175,000 sh | $5.64 | $987,000 | No record |
GTCR Co-Invest XIDirector | Maravai Lifesciences HoldingsMRVI | Open-market sale | 24/05/28 | 24/05/30 | 9,940,974 sh | $9.82 | $97,620,364.68 | −33.0% |
GTCR Fund Xi/BDirector | Maravai Lifesciences HoldingsMRVI | Open-market sale | 24/05/28 | 24/05/30 | 9,940,974 sh | $9.82 | $97,620,364.68 | −33.0% |
GTCR Fund Xi/CDirector | Maravai Lifesciences HoldingsMRVI | Open-market sale | 24/05/28 | 24/05/30 | 9,940,974 sh | $9.82 | $97,620,364.68 | −33.0% |
GTCR Partners Xi/BDirector | Maravai Lifesciences HoldingsMRVI | Open-market sale | 24/05/28 | 24/05/30 | 9,940,974 sh | $9.82 | $97,620,364.68 | −33.0% |
GTCR Investment XIDirector | Maravai Lifesciences HoldingsMRVI | Open-market sale | 24/05/28 | 24/05/30 | 9,940,974 sh | $9.82 | $97,620,364.68 | −33.0% |
GTCR Partners XI/A&CDirector | Maravai Lifesciences HoldingsMRVI | Open-market sale | 24/05/28 | 24/05/30 | 9,940,974 sh | $9.82 | $97,620,364.68 | −33.0% |
Maravai Life Sciences Holdings 2Director | Maravai Lifesciences HoldingsMRVI | Open-market sale | 24/05/28 | 24/05/30 | 9,940,974 sh | $9.82 | $97,620,364.68 | −33.0% |
Maravai Life Sciences HoldingsDirector | Maravai Lifesciences HoldingsMRVI | Open-market sale | 24/05/28 | 24/05/30 | 9,940,974 sh | $9.82 | $97,620,364.68 | −33.0% |